About Bikanta
Bikanta is a company based in Berkeley (United States) founded in 2013. Bikanta has raised $120 thousand across 1 funding round from investors including Y Combinator. The company has 6 employees as of December 31, 2021. Bikanta offers products and services including Optical Imaging Technology and Biotech Research Platforms. Bikanta operates in a competitive market with competitors including Denali Therapeutics, MiRagen, Poseida Therapeutics, Juno Therapeutics and Castle Biosciences, among others.
- Headquarter Berkeley, United States
- Employees 6 as on 31 Dec, 2021
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bikanta
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$120 K (USD)
in 1 rounds
-
Latest Funding Round
$120 K (USD), Seed
Jul 16, 2014
- Investors
-
Employee Count
6
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bikanta
Bikanta offers a comprehensive portfolio of products and services, including Optical Imaging Technology and Biotech Research Platforms.
Provides tools for molecular-level biological imaging and analysis
Offers platforms for cellular-level medical diagnostics and innovation
People of Bikanta
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Bikanta
Bikanta has successfully raised a total of $120K through 1 strategic funding round. The most recent funding activity was a Seed round of $120 thousand completed in July 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Bikanta
Bikanta has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Y Combinator.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are accelerated via funding and educational programs.
|
Locked | Locked | Locked |
Investor details for Bikanta
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bikanta
Investment portfolio details for Bikanta
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bikanta
Detailed financials for Bikanta
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bikanta Comparisons
Peer comparison for Bikanta
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bikanta
Bikanta operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Denali Therapeutics, MiRagen, Poseida Therapeutics, Juno Therapeutics and Castle Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| Locked | Locked | Locked |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| Locked | Locked | Locked |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| Locked | Locked | Locked |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
|
|
| Locked | Locked | Locked |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
|
| Locked | Locked | Locked |
Proprietary lab-on-chip platform for nanoparticle isolation is offered.
|
Detailed competitors of Bikanta
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bikanta
Complete news archive for Bikanta
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bikanta
Bikanta was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Bikanta is headquartered in Berkeley, United States. It is registered at Berkeley, California, United States.
Bikanta is a funded company, having raised a total of $120K across 1 funding round to date.
As of Dec 31, 2021, the latest employee count at Bikanta is 6.
Bikanta was founded in 2013 in Berkeley, United States, within the biotechnology sector. Nanodiamond-based molecular probes are developed by the company for cancer imaging, featuring fluorescence, stability, and non-toxicity for background-free optical detection. These probes are coated with customizable layers that can be bound to aptamers, biotin, DNA, antibodies, or other moieties for targeted diagnostics. Custom scanners are also being developed for probe detection, with initial focus on metastatic microtumors.
Bikanta's top competitors include Juno Therapeutics, Personalis and Poseida Therapeutics.
Bikanta offers Optical Imaging Technology and Biotech Research Platforms.
Bikanta has 1 investor. Key investors include Y Combinator.